Latest News

Iktos announces strategic collaboration with Cube biotech

Iktos announces strategic collaboration with Cube biotech

We are thrilled to announce our strategic partnership with Cube Biotech! The synergy between Cube Biotech's advanced membrane protein technology and Iktos' AI-driven drug discovery platform will help us develop novel small molecule agonists of the Amylin Receptor — a target with transformative potential for addressing obesity, diabetes, and other cardiometabolic disorders.

Press release

Iktos announces strategic collaboration with Cube biotech
01.13.2025

Iktos announces strategic collaboration with Cube biotech

Iktos appoints new Scientific Advisory Board
10.17.2024

Iktos appoints new Scientific Advisory Board

Iktos announces the acquisition of Synsight
07.08.2024

Iktos announces the acquisition of Synsight

Press articles and news

Iktos: the marriage of AI and robotics in the service of drug discovery

Iktos: the marriage of AI and robotics in the service of drug discovery

Our CEO, Yann Gaston-Mathé, shared Iktos’ story and vision in a recent interview with Techniques de l'Ingénieur.

Iktos: the marriage of AI and robotics in the service of drug discovery
Genetic Engineering & Biotechnology | 01.07.2025

Iktos: the marriage of AI and robotics in the service of drug discovery

The future of generative AI and automation in drug discovery
Innovations in Pharmaceutical Technology | 12.06.2024

The future of generative AI and automation in drug discovery

Iktos wins "Best Digital Innovation" at the Alliancy awards
Alliancy | 12.05.2024

Iktos wins "Best Digital Innovation" at the Alliancy awards

Press Kit

Photographies
PhotographiesDownload
Contact

Contact

For any communication need please contact our agency.

Ulysse Communication
Mail :  iktosteam@ulysse-communication.com
Tel. : +33663665922